2015
DOI: 10.2215/cjn.02330315
|View full text |Cite
|
Sign up to set email alerts
|

Renal Outcomes in Critically Ill Patients Receiving Propofol or Midazolam

Abstract: Background and objectives Propofol has been shown to provide protection against renal ischemia/reperfusion injury experimentally, but clinical evidence is limited to patients undergoing cardiac surgery. There are no data about its association with oliguria and AKI in critically ill patients.Design, setting, participants, & measurements We obtained data from the Multiparameter Intelligent Monitoring in Intensive Care II database (2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008). Patient selection criteria includ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
14
0
1

Year Published

2017
2017
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(17 citation statements)
references
References 21 publications
2
14
0
1
Order By: Relevance
“…In another study, patients treated with propofol had better ICU survival than those treated with benzodiazepine. The outcomes for patients in the ICU that were exclusively treated with propofol or midazolam were compared for the first 48 h. Patients treated with propofol had a lower risk of AKI, fluid-related complications, and less need for RRT compared with midazolam [62]. …”
Section: General Anesthesiamentioning
confidence: 99%
“…In another study, patients treated with propofol had better ICU survival than those treated with benzodiazepine. The outcomes for patients in the ICU that were exclusively treated with propofol or midazolam were compared for the first 48 h. Patients treated with propofol had a lower risk of AKI, fluid-related complications, and less need for RRT compared with midazolam [62]. …”
Section: General Anesthesiamentioning
confidence: 99%
“…This analysis might be enhanced by somehow incorporating predictors from the current hospitalization. We re-emphasize that no causal inference can be performed in this study, but interesting findings include tacrolimus (known nephrotoxicity [76]), midazolam (this association has been shown relative to propofol [77]), and oxycodone (opioid nephrotoxicity is currently researched [78]). It is worth highlighting the counter-intuitive finding that ibuprofen administration in prior hospitalizations is a negative predictor for AKI.…”
Section: Plosmentioning
confidence: 88%
“…The protective effect of intravenous anesthetic agents with a short duration on the liver and kidneys would be associated with non-specific histopathologic findings (36)(37)(38).…”
Section: Discussionmentioning
confidence: 99%